Blood molecules may unlock secrets of pancreatic cancer
NCT ID NCT04406831
First seen May 03, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This study is looking at tiny molecules called microRNAs in the blood of people with advanced pancreatic cancer. The goal is to see if these molecules can help doctors diagnose the disease earlier, predict how it will progress, and determine which treatments might work best. Researchers will collect blood samples from 200 participants over time to analyze these patterns.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Nuvance Health
RECRUITINGNorwalk, Connecticut, 06856, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.